These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2229772)

  • 21. Effect of basic drive cycle length on the yield of ventricular tachycardia during programmed ventricular stimulation.
    Summitt J; Rosenheck S; Kou WH; Schmaltz S; Kadish AH; Morady F
    Am J Cardiol; 1990 Jan; 65(1):49-52. PubMed ID: 2294680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA; Murdock CJ; Boone J; Kerr CR
    J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
    Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction.
    Morady F; Kadish A; Rosenheck S; Calkins H; Kou WH; De Buitleir M; Sousa J
    J Am Coll Cardiol; 1991 Mar; 17(3):678-89. PubMed ID: 1993788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of ventricular fibrillation versus monomorphic ventricular tachycardia during programmed stimulation. Role of premature beat conduction delay.
    Avitall B; McKinnie J; Jazayeri M; Akhtar M; Anderson AJ; Tchou P
    Circulation; 1992 Apr; 85(4):1271-8. PubMed ID: 1372847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Late ventricular potentials and spontaneous and electric stimulation-induced ventricular tachycardia].
    Dabrowski A; Kubik L; Kołodziej P; Krupienicz A; Ponikwicka E
    Kardiol Pol; 1990; 33(7):12-6. PubMed ID: 2259059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential effect of procainamide on the reentrant circuit of ventricular tachycardia.
    Kay GN; Epstein AE; Plumb VJ
    J Am Coll Cardiol; 1989 Aug; 14(2):382-90. PubMed ID: 2754127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic variables characterizing the induction of ventricular tachycardia versus ventricular fibrillation after myocardial infarction: relation between ventricular late potentials and coupling intervals for the induction of sustained ventricular tachyarrhythmias.
    Martinez-Rubio A; Shenasa M; Borggrefe M; Chen X; Benning F; Breithardt G
    J Am Coll Cardiol; 1993 Jun; 21(7):1624-31. PubMed ID: 8496529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of propafenone-induced slowing of ventricular tachycardia in man as defined by analysis of resetting response patterns.
    Callans DJ; Hook BG; Josephson ME
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2035-41. PubMed ID: 1721220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between QT interval duration and electrical induction of ventricular tachycardia.
    Dabrowski A; Kolodziej P; Krupienicz A
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):366-9. PubMed ID: 1706854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M; Steinbeck G; Lüderitz B
    Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
    Musto B; D'Onofrio A; Musto A; Cavallaro C; Marsico F
    G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of pace mapping QRS configuration and conduction delay to ventricular tachycardia reentry circuits in human infarct scars.
    Stevenson WG; Sager PT; Natterson PD; Saxon LA; Middlekauff HR; Wiener I
    J Am Coll Cardiol; 1995 Aug; 26(2):481-8. PubMed ID: 7608454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome.
    Dubuc M; Kus T; Campa MA; Lambert C; Rosengarten M; Shenasa M
    Am Heart J; 1989 Feb; 117(2):370-6. PubMed ID: 2644795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
    Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency-dependent effects of propafenone decrease with duration of ventricular tachycardia in isolated guinea pig hearts.
    Stark G; Dhein S; Bachernegg M; Ziskoven U; Zhao Y; Klaus W; Kickenweiz E; Decrinis M; Tritthart HA
    Eur J Pharmacol; 1994 Feb; 252(3):283-9. PubMed ID: 8162951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.
    Aizawa Y; Chinushi M; Kitazawa H; Washizuka T; Abe A; Shibata A; Kodama I
    Heart; 1996 Mar; 75(3):281-6. PubMed ID: 8800993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
    Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
    Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of antiarrhythmic efficacy of propafenone as assessed by programmed electrical stimulation in conscious dogs.
    Todt H; Krumpl G; Krejcy K; Raberger G
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):341-8. PubMed ID: 1378111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug response at electropharmacologic study in patients with ventricular tachyarrhythmias: the importance of ventricular refractoriness.
    Gillis AM; Wyse DG; Duff HJ; Mitchell LB
    J Am Coll Cardiol; 1991 Mar; 17(4):914-20. PubMed ID: 1999629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.